<DOC>
	<DOCNO>NCT02393547</DOCNO>
	<brief_summary>This open label clinical trial subject receive lorcaserin varenicline primary aim reduce post cessation weight gain .</brief_summary>
	<brief_title>Lorcaserin Preventing Weight Gain Among Smokers</brief_title>
	<detailed_description>This open label clinical trial subject receive lorcaserin varenicline . The investigator obtain preliminary data efficacy lorcaserin ( 10 mg twice daily ) 12 week 20 adult weight-concerned cigarette smoker BMI 27 40 simultaneously receive 12 week open-label varenicline behavioral intervention assist stop smoking . Secondary aim weight , waist circumference , smoke cessation .</detailed_description>
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Weight Gain</mesh_term>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>1 . ≥18 year ≤65 year age ; 2. smoke ≥10 cigarettes/day past 6 month ; 3 . BMI 2740 kg/m2 ; 4. resides within Olmsted County area ; 5. motivate stop smoking ; 6. weight concern show Weight Concern Scale ; 7. able participate fully aspects study ; 8. understood sign study inform consent . 1. current nonspecific suicidal thought lifetime history suicidal attempt ( define ColumbiaSuicide Severity Rating Scale [ CSSRS ] `` potentially selfinjurious act commit least wish die , result act . `` ) ; 2. current moderate severe depression assess score ≥16 Center Epidemiologic StudiesDepression ( CESD ) ; 3. lifetime history bipolar disorder schizophrenia ; 4. use antipsychotic medication within past 30 day ; 5. use weightloss medication within past 30 day current participation program specifically design help weight loss ; 6. weight fluctuation 20 pound past 6 month ( selfreport ) ; 7. use treatment tobacco dependence within past 30 day ; 8. use investigational drug within past 30 day ; 9. recent history ( past 3 month ) abuse dependence substance tobacco ; 10. current use benzodiazepine , narcotic , antiepileptic , medication know interact lorcaserin ( see human subject section ) ; 11. current use triptans , monoamine oxidase inhibitor , selective serotonin reuptake inhibitor ( SSRIs ) , selective serotoninnorepinephrine reuptake inhibitor ( SNRIs ) , dextromethorphan , tricyclic antidepressant ( TCAs ) , bupropion , lithium , tramadol , tryptophan , St. John 's Wort , medication know involve serotonergic neurotransmitter system ( see human subject section ) ; 12. uncontrolled hypertension ( systolic &gt; 160 mm Hg and/or diastolic &gt; 100 mm Hg ) document 2 separate occasion ; 13. clinically significant acute chronic progressive unstable neurologic , hepatic , renal , cardiovascular , respiratory , metabolic disease ; 14. current use medication know interact varenicline lorcaserin ; 15. another household member relative participating study ; 16 . Known Diabetes ; 17. know allergy varenicline lorcaserin ; 18. take antibiotic within past 3 month . 19 . Women pregnant lactating , childbearing potential likely become pregnant medication phase willing use reliable form contraception , also exclude . Reliable form contraception include oral contraception , diaphragm condom ( spermicide ) , injection , intrauterine device , surgical sterilization , abstinence .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>obesity</keyword>
</DOC>